during emergency responses. Sec. 306. National advisory committees. Sec. 307. Research and coordination of activities concerning the long-term health effects of SARS–CoV–2 infection. Sec. 308. National Academies study on prizes. TITLE IV—Strengthening biosecurity Sec. 401. Treatment of genetic variants and synthetic products of select agents and toxins. Sec. 402. Establishment of no-fault reporting system. Sec. 403. Evaluation of the Federal Select Agent Program and related policies. Sec. 404. Supporting research and laboratory surge capacity. Sec. 405. Gene synthesis. Sec. 406. Limitation related to countries of concern conducting certain research. Sec. 407. Assessment of artificial intelligence threats to health security. TITLE V—Preventing drug shortages Sec. 501. Improving notification procedures in case of increased demand for critical drugs. Sec. 502. Reporting on supply chains. Sec. 503. Reporting on use of new authorities and requirements with respect to drug shortages. TITLE VI—Additional reauthorizations and technical amendments Sec. 601. Medical countermeasure priority review voucher. Sec. 602. Epidemic Intelligence Service loan repayment program. Sec. 603. Vaccine tracking and distribution. Sec. 604. Regional health care emergency preparedness and response systems. Sec. 605. Emergency system for advance registration of volunteer health professional. Sec. 606. Limited antitrust exemption. Sec. 607. Trauma care. Sec. 608. Military and civilian partnership for trauma readiness. Sec. 609. National Disaster Medical System. Sec. 610. Volunteer Medical Reserve Corps. Sec. 611. Epidemiology-laboratory capacity grants. Sec. 612. Veterans Affairs. Sec. 613. Technical amendments. I State and local readiness and response 101. Temporary reassignment of State and local personnel during a public health emergency Section 319(e) of the Public Health Service Act ( 42 U.S.C. 247d(e) ) is amended— (1) in paragraph (1), by striking tribal organization or such Governor or tribal organization's designee and inserting